4.6 Article

Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing

Related references

Note: Only part of the references are listed.
Review Virology

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics

Wenbing Wu et al.

Summary: Coronavirus disease 2019 (COVID-19) continues to have devastating effects on personal health, healthcare systems, and global economies. Efforts are being made to develop diagnostic technologies for early detection of infections, as well as vaccines and drugs for prevention and treatment. However, concerns are rising due to the emergence of new variants that may affect vaccine efficacy. The nucleocapsid (N) protein of SARS-CoV-2 has gained attention for its role in the virus life cycle and its potential as a target for vaccines and diagnostic techniques. This article provides a summary of the latest research on the N protein, including its functions, structure, post-translational modifications, and involvement in liquid-liquid phase separation (LLPS).

VIROLOGY JOURNAL (2023)

Article Virology

Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020-2022

Jiratchaya Puenpa et al.

Summary: This study investigated the molecular characteristics and evolution of SARS-CoV-2 in Thailand from 2020 to 2022. The results showed that different variants, including B.1.36.16, B.1.1.7, B.1.617.2, and B.1.1.529, caused outbreaks in different waves. Continued molecular surveillance is crucial for monitoring emerging variants.

ARCHIVES OF VIROLOGY (2023)

Article Biochemistry & Molecular Biology

Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification

Hannah T. Baddock et al.

Summary: The nsp14-nsp10 complex of SARS-CoV-2 has been found to possess RNase activity and is capable of digesting various RNA structures. Its activity is enhanced by the viral RNA-dependent RNA polymerase complex nsp12-7-8. Inhibitors of nsp14-nsp10, including ebselen and raltegravir, have been identified and may have potential use in the treatment of COVID-19.

NUCLEIC ACIDS RESEARCH (2022)

Article Multidisciplinary Sciences

Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong

Haogao Gu et al.

Summary: Hong Kong has successfully controlled the transmission of SARS-CoV-2 through an elimination strategy and stringent measures. The majority of community-acquired cases were caused by three importations, and increased transmission occurred after prolonged restrictions, possibly due to adherence fatigue. Strong border control and community surveillance are essential for preventing local outbreaks.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load

Tobias Mourier et al.

Summary: Monitoring the spread and evolution of SARS-CoV-2 through genome sequencing is crucial in managing the COVID-19 pandemic. In this study, the authors sequenced 892 SARS-CoV-2 genomes collected from patients in Saudi Arabia and identified two consecutive mutations in the nucleocapsid protein that were associated with higher viral loads in COVID-19 patients. Through biochemical analysis, they found that the mutant protein displayed enhanced viral RNA binding and differential interaction with key host proteins. The study also revealed dysregulated interferon response genes in host cells expressing the mutant protein. These findings provide important insights into the modulation of host-virus interactions and highlight the potential of the nucleocapsid protein as a target for drug development during infection.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Evolution of the SARS-CoV-2 spike protein in the human host

Antoni G. Wrobel et al.

Summary: Recently emerged variants of SARS-CoV-2, such as Alpha and Beta, have spike glycoproteins with multiple substitutions that increase transmission and resistance to neutralizing antibodies. The spike proteins of these variants have acquired mutations that affect receptor binding and stability upon binding. This research provides insights into the evolution of the virus and its ability to transmit in humans.

NATURE COMMUNICATIONS (2022)

Review Microbiology

Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19

Jiantao Zhang et al.

Summary: This article reviews the current literature on the viral protein ORF3a of SARS-CoV-2, highlighting its role in viral pathogenesis and COVID-19. ORF3a is a polymorphic protein that interferes with ion channel activities, induces cellular immune and inflammatory responses, and leads to cell death and tissue damage. It continues to evolve to adapt to the human cellular environment. However, the effects of emerging ORF3a mutations and their role in COVID-19 are largely unknown.

FRONTIERS IN MICROBIOLOGY (2022)

Article Infectious Diseases

Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection

Bo Diao et al.

Summary: The FIC assay for NP antigen testing shows high specificity and relatively high sensitivity in early-phase SARS-CoV-2 diagnosis, according to a study conducted in Wuhan and Chongqing between February 10 and 15, 2020.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Microbiology

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney et al.

Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.

CELL HOST & MICROBE (2021)

Article Microbiology

Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2

Haibo Wu et al.

Summary: The study found that the co-occurring mutations R203K/G204R on the SARS-CoV-2 nucleocapsid protein contribute to the emergence of high-transmissibility variants with replication advantages. These variants show increased infectivity in human lung cells and hamsters, with a positive association observed between increased COVID-19 severity and sample frequency of these mutations.

CELL HOST & MICROBE (2021)

Article Multidisciplinary Sciences

Emergence of B.1.524(G) SARS-CoV-2 in Malaysia during the third COVID-19 epidemic wave

Kim-Kee Tan et al.

Summary: The COVID-19 pandemic first emerged in Malaysia in January 2020, with a total of 1,979,698 confirmed cases reported as of September 12, 2021. The study identified multiple independent introductions of SARS-CoV-2 into Malaysia, with a new B.1.524(G) lineage detected during the second and third waves of the epidemic. This lineage carried unique genetic variations, including mutations in the Spike protein and 5'UTR. The sequential appearance of mutations suggested a spread from Sabah to Selangor within Malaysia.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Identification and functional analysis of the SARS-COV-2 nucleocapsid protein

Tianyi Gao et al.

Summary: This study analyzed the physicochemical properties, subcellular localization, and biological function of the SARS-COV-2N protein. The identification of 12 phosphorylated sites and 9 potential protein kinase sites in the SARS-COV-2N protein may serve as promising targets for drug discovery and development of a recombinant virus vaccine.

BMC MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

The phylogenetic relationship within SARS-CoV-2s: An expanding basal Glade

Steve Shen et al.

Summary: The study identified a basal SARS-CoV-2 Glade representing the least mutated viral sequence over at least four months. The findings suggest that SARS-CoV-2 may possess an unprecedented RNA proofreading capability, maintaining genome integrity even after extensive transmission.

MOLECULAR PHYLOGENETICS AND EVOLUTION (2021)

Article Genetics & Heredity

Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology

Madhvi Joshi et al.

Summary: Humanity has witnessed various pandemics throughout history, including measles, Ebola, SARS, and MERS. The latest addition is COVID-19 caused by the novel coronavirus SARS-CoV-2. Genomic studies have revealed mutations in the virus, with certain variants associated with increased mortality rates. In India, Gujarat has been significantly affected by COVID-19 with a higher death rate compared to the national average, and genomic analysis has identified key mutations linked to mortality in patients.

FRONTIERS IN GENETICS (2021)

Article Medical Laboratory Technology

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia

Daniel K. W. Chu et al.

CLINICAL CHEMISTRY (2020)

Article Virology

Transmission dynamics and evolutionary history of 2019-nCoV

Xingguang Li et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Biochemistry & Molecular Biology

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting

Fran Robson et al.

MOLECULAR CELL (2020)

Article Virology

Phylogenetic and phylodynamic analyses of SARS-CoV-2

Qing Nie et al.

VIRUS RESEARCH (2020)

Article Virology

Temporal signal and the phylodynamic threshold of SARS-CoV-2

Sebastian Duchene et al.

VIRUS EVOLUTION (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Lizhou Zhang et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Mei-Yue Wang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Infectious Diseases

Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission

Sayantan Laha et al.

INFECTION GENETICS AND EVOLUTION (2020)

Article Biochemistry & Molecular Biology

The EMBL-EBI search and sequence analysis tools APIs in 2019

Fabio Madeira et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Virology

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10

Marc A. Suchard et al.

VIRUS EVOLUTION (2018)

Article Biochemistry & Molecular Biology

MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0

Koichiro Tamura et al.

MOLECULAR BIOLOGY AND EVOLUTION (2013)

Article Virology

Comparison of the mutation rates of human influenza A and B viruses

E Nobusawa et al.

JOURNAL OF VIROLOGY (2006)